Helen Nankervis

King's Meadow Campus, Lenton Lane
Nottingham, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Knowledge-to-care: is there a best way of support practitioners to getting evidence into practice? An ongoing debate.

Knowledge-to-care: is there a best way of support practitioners to getting evidence into practice? An ongoing debate.

Journal: Evidence & policy : a journal of research, debate and practice

Published: January 29, 2025

The effect of two speech and language approaches on speech problems in people with Parkinson's disease: the PD COMM RCT.

The effect of two speech and language approaches on speech problems in people with Parkinson's disease: the PD COMM RCT.

Journal: Health technology assessment (Winchester, England)

Published: October 04, 2024

Lee Silverman voice treatment versus NHS speech and language therapy versus control for dysarthria in people with Parkinson's disease (PD COMM): pragmatic, UK based, multicentre, three arm, parallel group, unblinded, randomised controlled trial.

Lee Silverman voice treatment versus NHS speech and language therapy versus control for dysarthria in people with Parkinson's disease (PD COMM): pragmatic, UK based, multicentre, three arm, parallel group, unblinded, randomised controlled trial.

Journal: BMJ (Clinical research ed.)

Published: July 10, 2024

Help for Future Research: Lessons Learned in Trial Design, Recruitment, and Delivery From the "hELP" Study.

Help for Future Research: Lessons Learned in Trial Design, Recruitment, and Delivery From the "hELP" Study.

Journal: Journal of lower genital tract disease

Published: July 06, 2018

More Atopic Dermatitis Trials Using Standard Treatments as Active Comparators, Please.

More Atopic Dermatitis Trials Using Standard Treatments as Active Comparators, Please.

Journal: The Journal of investigative dermatology

Published: February 16, 2017

What is the evidence base for atopic eczema treatments? A summary of published randomized controlled trials.

What is the evidence base for atopic eczema treatments? A summary of published randomized controlled trials.

Journal: The British journal of dermatology

Published: August 09, 2016

Evaluation of the measurement properties of symptom measurement instruments for atopic eczema: a systematic review.

Evaluation of the measurement properties of symptom measurement instruments for atopic eczema: a systematic review.

Journal: Allergy

Published: June 18, 2016

Specific allergen immunotherapy for the treatment of atopic eczema: a Cochrane systematic review.

Specific allergen immunotherapy for the treatment of atopic eczema: a Cochrane systematic review.

Journal: Allergy

Published: May 07, 2016

How Clinically Relevant Are Treatment Comparisons of Topical Calcineurin Inhibitor Trials for Atopic Eczema?

How Clinically Relevant Are Treatment Comparisons of Topical Calcineurin Inhibitor Trials for Atopic Eczema?

Journal: The Journal of investigative dermatology

Published: April 13, 2016

Reporting of symptoms in randomized controlled trials of atopic eczema treatments: a systematic review.

Reporting of symptoms in randomized controlled trials of atopic eczema treatments: a systematic review.

Journal: The British journal of dermatology

Published: March 21, 2016

Specific allergen immunotherapy for the treatment of atopic eczema.

Specific allergen immunotherapy for the treatment of atopic eczema.

Journal: The Cochrane database of systematic reviews

Published: February 13, 2016

Eczema Trials: Quality of Life Instruments Used and Their Relation to Patient-reported Outcomes. A Systematic Review.

Eczema Trials: Quality of Life Instruments Used and Their Relation to Patient-reported Outcomes. A Systematic Review.

Journal: Acta dermato-venereologica

Published: December 18, 2015

Showing 1-12 of 22

Last Updated: 09/26/2026